Commonly referenced guidance includes: Initial replacement Maintenance For maintenance, the BNF lists adult prophylaxis/maintenance dosing such as 1 mg intramuscularly every 23 months in appropriate cases
Baseline renal function was normal or mildly impaired in 91% of patients and moderately impaired in 9% of patients (mean eGFR 86.8 mL/min/1.73 m2)
It is often discussed for recovery, sleep, body composition, and age-related hormone support, but results vary
Steady-state drug exposure is not achieved for several additional weeks after that, meaning the full pharmacological effect requires roughly 20-24 weeks to manifest
Zhang X, Zhang L, Cheng X, Guo Y, Sun X, Chen G, Li H, Li P, Lu X, Tian M, et al
These technologies enhance operational efficiency, improve patient retention, and support the expansion of IV therapy services across multiple locations